We report a case of bilateral hearing loss in a patient treated with intravenous erythromycin lactobionate. The ototoxic reaction occurred despite the patient's having normal renal and hepatic function and the fact that serum erythromycin levels were within the predicted normal range. In addition to hearing loss, a marked labyrinthic hyporreflexia was also observed. Hearing loss improved after the treatment was discontinued, but labyrinthic abnormalities persisted suggesting that erythromycin had caused a permanent vestibular damage.
(Arch Intern Med. 1991;151:380)
Agustí C, Ferrán F, Gea J, Picado C. Ototoxic Reaction to Erythromycin. Arch Intern Med. 1991;151(2):380. doi:10.1001/archinte.1991.00400020124025
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: